Most ALS patients have a hereditary component, with mutations in C9orf72, TARDBP (also known as TDP43), SOD1 (superoxide dismutase 1), and FUS2 (Fused in sarcoma 2) accounting for the vast majority of cases [161]. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.